В. М. Мицура
Gomel State Medical University · 146 works · 518 citations · h-index 12
Top works
- Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study
- Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015
- Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
- Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
- Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study
- Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals.
- Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy
- Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
- Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
- Molecular and genetic properties of hepatitis b virus and their clinical role in chronic hepatitis B
- Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study
- Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression
- Healthcare delivery for HIV‐positive people with tuberculosis in Europe
- Increases in acute hepatitis C (HCV) incidence across Europe: which regions and patient groups are affected?
- Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe
- Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis
- Prevalence and outcomes of pregnancies in women with HIV over a 20-year period
- Yersiniosis with fever of unclear genesis
- Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
- Long term effectiveness of once‐daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression